They also inhibit the TLR4 and NLRP3 signaling pathways, reducing the production of inflammatory cytokines such as IL-1β, TNF-α, and IL-6, thereby lowering the incidence of NEC [33]. The gene discussed is TLR4; the disease is necrotizing enterocolitis.